Date / Time | Nov. 18 (Thu), 08:30-10:00 | |
---|---|---|
Channel | Channel 1 | |
Chair(s) |
Myung Seok Lee (Hallym Univ., Korea) Jong Eun Yeon (Korea Univ., Korea) |
|
Speakers | 08:30-08:52 | Viral hepatitis Hyun Woong Lee (Yonsei Univ., Korea) |
08:52-09:14 | Alcoholic and nonalcoholic liver disease Byoung Kuk Jang (Keimyung Univ., Korea) | |
09:14-09:36 | Liver cirrhosis and complications Byung Seok Kim (Daegu Catholic Univ., Korea) | |
09:36-09:58 | Hepatocellular carcinoma Jooho Lee (CHA Univ., Korea) |
Date / Time | Nov. 18 (Thu), 08:30-10:00 | |
---|---|---|
Channel | Channel 2 | |
Chair(s) |
Suck Chei Choi (Wonkwang Univ., Korea) Sutep Gonlachanvit (Chulalongkorn Univ., Thailand) |
|
Speakers | 08:30-08:50 | Epidemiology Young Sin Cho (Soonchunhyang Univ., Korea) |
08:50-09:10 | Diagnostic approach Han Seung Ryu (Wonkwang Univ., Korea) | |
09:10-09:30 | Novel pharmacologic treatment Seon-Young Park (Chonnam National Univ., Korea) | |
09:30-09:50 | Non-medical treatment for refractory constipation Sutep Gonlachanvit (Chulalongkorn Univ., Thailand) | |
09:50-10:00 | Discussion |
Date / Time | Nov. 18 (Thu), 08:30-10:00 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Jong Ho Moon (Soonchunhyang Univ., Korea) Jin Hong Kim (Ajou Univ., Korea) |
|
Speakers | 08:30-08:52 | Up-to-date of cholangioscopy: From percutaneous to SOC Yun Nah Lee (Soonchunhyang Univ., Korea) |
08:52-09:14 | Optimal endoscopic drainage strategy Itaru Naitoh (Nagoya City Univ., Japan) | |
09:14-09:36 | Efficacy of RFA and applying strategy Huapyong Kang (Gachon Univ., Korea) | |
09:36-09:58 | Surgical palliation after neoadjuvant chemotherapy Sung Hoon Choi (CHA Univ., Surgery, Korea) |
Date / Time | Nov. 18 (Thu), 08:30-10:00 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Chong-Il Sohn (Sungkyunkwan Univ., Korea) Hidekazu Suzuki (Tokai Univ. School of Medicine, Japan) Ching-Liang Lu (National Yang Ming Chiao Tung Univ., Taiwan) |
|
Discussant(s) | Myong Ki Baeg (Catholic Kwandong Univ., Korea) Mariko Hojo (Juntendo Univ. School of Medicine, Japan) Chien-Lin Chen (Hualien Tzu Chi Hosp., Taiwan) |
|
Speakers | 08:30-08:50 | Usefulness of high-resolution manometry for the management of oropharyngeal dysphagia Jung Ho Park (Kangbuk Samsung Hosp., Korea) |
08:50-09:10 | Functional dyspepsia -Diagnosis and treatment- Tadayuki Oshima (Hyogo College of Medicine, Japan) | |
09:10-09:30 | Esophageal mucosal histopathology may help differentiate achalasia from refractory gastroesophageal reflux disease Ping-Huei Tseng (National Taiwan Univ. Hosp., Taiwan) | |
09:30-09:40 | New parameter for quantifying bolus transit with high-resolution impedance manometry Eun Jeong Gong (Univ. of Ulsan, Korea) | |
09:40-09:50 | Assessment of esophagogastric junction in post-POEM reflux esophagitis Akinari Sawada (Osaka City Univ. Graduate School of Medicine, Japan) | |
09:50-10:00 | Comparison of manometric diagnosis by Chicago classification version 3.0 and 4.0 on esophageal high resolution manometry Yen-Po Wang (Taipei Veterans General Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 08:30-10:00 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Chang Hwan Choi (Chung-Ang Univ., Korea) Byong Duk Ye (Univ. of Ulsan, Korea) |
|
Speakers | 08:30-08:52 | Can endoscopic disease activity predict the clinical outcome of IBD? Kyeong Ok Kim (Yeungnam Univ., Korea) |
08:52-09:14 | Surveillance colonoscopy for dysplasia: How to optimize it in daily practice Won Moon (Kosin Univ., Korea) | |
09:14-09:36 | Colitis-associated dysplasia: Resect it or remove the entire colon? Dong-Hoon Yang (Univ. of Ulsan, Korea) | |
09:36-09:58 | Role and limitation of endoscopic intervention for Crohn's strictures Jinsu Kim (The Catholic Univ. of Korea, Korea) |
Date / Time | Nov. 18 (Thu), 08:30-09:20 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Byung Ik Kim (Sungkyunkwan Univ, Korea) Joo Hyun Sohn (Hanyang Univ., Korea) |
|
Speakers | 08:30-08:40 | Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults: A Nationwide Population-Based Study Jeong-Ju Yoo (SoonChunHyang Univ. Bucheon Hosp., Korea) |
08:40-08:50 | The Impact of Pylorus Preservation on the Development of Non-Alcoholic Fatty Liver Disease after Pancreaticoduodenectomy; A Retrospective Study Dongsub Jeon (Asan Medical Center, Korea) | |
08:50-09:00 | Molecular Pathogenesis of Non-Alcoholic Steatohepatitis (NASH) through the Dysregulation of Metabolic Organ Network in the NASH-HCC Model Mouse Treated with Streptozotocin-High Fat Diet Linh Bui Phuong (SMC Laboratories Inc., Japan) | |
09:00-09:10 | The Association between Alanine Aminotransferase (ALT) and Waist Circumference in Young Adults Tulio Correa (Federal Univ. of Pelotas, Brazil) | |
09:10-09:20 | Association of Triglyceride-Glucose Index and Hba1C with the Degree of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease Evaluated by Acoustic Radiation Force Impulse Imaging Jan Catherine Carrera (Chong Hua Hosp., Philippines) |
Date / Time | Nov. 18 (Thu), 09:20-10:00 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Changhyeong Lee (Daegu Catholic Univ., Korea) Tae Hun Kim (Ewha Womans Univ., Korea) |
|
Speakers | 09:20-09:30 | Simultaneous Analysis of Plasma Metabolomics and Genetic Variants in Pediatric Nonalcoholic Fatty Liver Disease Kyung Jae Lee (Hallym Univ. Sacred Heart Hosp., Korea) |
09:30-09:40 | Stratification by Non-Invasive Biomarkers of Non-Alcoholic Fatty Liver Disease in Children Yiyoung Kwon (Samsung Medical Center, Korea) | |
09:40-09:50 | Impact of Cigarette or E-Cigarette Exposure on Liver Function Parameter in High-Fat-Diet Induced Rats Naufal Arif Ismail (Universitas Islam Indonesia, Indonesia) |
Date / Time | Nov. 18 (Thu), 10:15-11:45 | |
---|---|---|
Channel | Channel 2 | |
Chair(s) |
Hyojin Park (Yonsei Univ., Korea) Hiroto Miwa (Hyogo Univ., Japan) |
|
Speakers | 10:15-10:35 | Epidemiology Hye-Kyung Jung (Ewha Womans Univ., Korea) |
10:35-10:55 | Pathogenesis Hiroto Miwa (Hyogo Univ., Japan) | |
10:55-11:15 | Medical treatment Jung Hwan Oh (The Catholic Univ. of Korea, Korea) | |
11:15-11:35 | Non-pharmacological treatment for functional dyspepsia Ching-Liang Lu (National Yang Ming Chiao Tung Univ., Taiwan) | |
11:35-11:45 | Discussion |
Date / Time | Nov. 18 (Thu), 10:15-11:45 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Ho Gak Kim (Daegu Catholic Univ., Korea) Yong-Tae Kim (Seoul National Univ., Korea) |
|
Speakers | 10:15-10:37 | Clinical application of novel biomarker for the diagnosis of pancreatobiliary cancer Sung Ill Jang (Yonsei Univ., Korea) |
10:37-10:59 | Feasibility of developing immune profiles of pancreatitis and pancreatic cancer Walter Park (Stanford Univ., USA) | |
10:59-11:21 | NK cell-based immunotherapies in pancreato-biliary cancer Kyung-Mi Lee (Korea Univ., Biochemistry, Korea) | |
11:21-11:43 | Double spiral microfluidic device for highly elaborated formation of circulating tumor cell-neutrophil clusters through deterministic encapsulation Hyo-Il Jung (Yonsei Univ., Mechanical Engineering, Korea) |
Date / Time | Nov. 18 (Thu), 10:15-11:45 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Joo Sung Kim (Seoul National Univ., Korea) Tadakazu Hisamatsu (Kyorin Univ. School of Medicine, Japan) Cheng-Tang Chiu (Linkou Chang Gung Memorial Hosp., Taiwan) |
|
Discussant(s) | Dong Il Park (Sungkyunkwan Univ., Korea) Masanao Nakamura (Nagoya Univ., Japan) Shu-Chen Wei (National Taiwan Univ. Hosp., Taiwan) |
|
Speakers | 10:15-10:35 | Early intervention in IBD: Why and how? Byong Duk Ye (Univ. of Ulsan, Korea) |
10:35-10:55 | Deep neural network for colonoscopy of ulcerative colitis Kento Takenaka (Tokyo Medical and Dental Univ. Hosp., Japan) | |
10:55-11:15 | Transmural healing: The dream or the ideal to be achieved Chen-Shuan Chung (Far Eastern Memorial Hosp., Taiwan) | |
11:15-11:25 | Big data research: Progress makes practice in IBD Jaeyoung Chun (Yonsei Univ., Korea) | |
11:25-11:35 | The role of endoscopy in inflammatory bowel disease Junji Umeno (Kyushu Univ. Hosp., Japan) | |
11:35-11:45 | Clostridium innocuum in inflammatory bowel disease Puo-hsien Le (Linkou Chang Gung Memorial Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 10:15-11:45 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Hyungkil Kim (Inha Univ., Korea) Jin Il Kim (The Catholic Univ. of Korea, Korea) |
|
Speakers | 10:15-10:37 | Recent guidelines of ESD for EGCa Tae Ho Kim (The Catholic Univ. of Korea, Korea) |
10:37-10:59 | WHO classifications of gastric cancer-pathology Sung Hak Lee (The Catholic Univ. of Korea, Pathology, Korea) | |
10:59-11:21 | ESD vs surgery for undifferentiated EGCa Ji Yong Ahn (Univ. of Ulsan, Korea) | |
11:21-11:43 | Management after non-curative resection for EGC Hyo-Joon Yang (Sungkyunkwan Univ., Korea) |
Date / Time | Nov. 18 (Thu), 10:15-10:45 | |
---|---|---|
Channel | Channel 1 | |
Chair | Dong Joon Kim (Hallym Univ., Korea) | |
Speaker | 10:15-10:45 | Beyond the best with humanity and creativity Kwang-Hyub Han (National Evidence-based Healthcare Collaborating Agency (NECA), Korea) |
Date / Time | Nov. 18 (Thu), 10:15-11:05 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Seungmin Bang (Yonsei Univ., Korea) Jae Jun Park (Yonsei Univ., Korea) |
|
Speakers | 10:15-10:25 | Interleukin-4 Induced PAK4 Promotes Cell Survival and Proliferation in Colorectal Cancer Cells through MAP2K4 Dependent JNK/p38 Signaling Pathway Se Lim Kim (Chonbuk National Univ. Hosp., Korea) |
10:25-10:35 | lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer Jungho Yoon (Severance Hosp., Korea) | |
10:35-10:45 | Immunoprofile Analysis to Investigate Prognostic Markers in Pancreaticobiliary Tract Cancers Ji Eun Kim (Samsung Medical Center, Korea) | |
10:45-10:55 | MRI of Glutamine Uptake in Cancers: Correlation with ASCT2 and Cancer Stem Cell Markers Yoojeong Seo (Yonsei Univ. College Of Medicine, Korea) | |
10:55-11:05 | Development of Drug Screening Platform Using PDAC Patient Avatar, PDAC Organoids Model: Chemotherapy Efficacy between Organoid and Real-World Data Yeji Shin (Samsung Medical Center, Korea) |
Date / Time | Nov. 18 (Thu), 10:45-11:45 | |
---|---|---|
Channel | Channel 1 |
Date / Time | Nov. 18 (Thu), 11:05-11:45 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Jai Hoon Yoon (Hanyang Univ., Korea) Yoonjae Kim (Gachon Univ., Korea) |
|
Speakers | 11:05-11:15 | Unraveling Tumor-Immune Heterogeneity and Suppressive Microenvironment in Pancreatic Ductal Adenocarcinoma Seung-Hoon PI (Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea) |
11:15-11:25 | Predictive Biomarkers to Chemotherapy in Patients with Pancreatic Cancer: Preliminary Results of a Prospective Cohort Study Jung Won Chun (National Cancer Center, Korea) | |
11:25-11:35 | Comparison of the Quantity and Size Distribution between Normal Cell Free DNA and Circulating Tumor DNA in Korean Colorectal Cancer Patients Sang Hyun Kim (Korea Univ. Anam Hosp., Korea) | |
11:35-11:45 | Treatment Patterns and Outcomes for Pancreatic Cancer Patients in Korea, 2006-2019: A Nationwide Population-Based Study Byung Kyu Park (National Health Insurance Service Ilsan Hosp., Korea) |
Date / Time | Nov. 18 (Thu), 11:45-12:25 | |
---|---|---|
Channel | Channel 4 | |
Chair | Jae J. Kim (Sungkyunkwan Univ., Korea) | |
Speaker | 11:45-12:25 | Prevention and management of NSAIDs - induced enteropathy Sang Gyun Kim (Seoul National Univ., Korea) |
Date / Time | Nov. 18 (Thu), 12:25-13:55 | |
---|---|---|
Channel | Channel 1 | |
Chair(s) |
Chul Ju Han (Korea Cancer Center Hosp., Korea) Yun Soo Kim (Gachon Univ., Korea) |
|
Speakers | 12:25-12:47 | The application of texture quantification in hepatocellular carcinoma using CT and MRI Kwang Gi Kim (Gachon Univ., Biomedical Engineering, Korea) |
12:47-13:09 | Next generation diagnostic pathology: Artificial intelligence-powered diagnosis and biomarker analysis Chan-Young Ock (Lunit Inc., Korea) | |
13:09-13:31 | Utilization of digital healthcare big data Young-Hak Kim (Univ. of Ulsan, Cardiology, Korea) | |
13:31-13:53 | Profiling based identification and application of non-coding RNAs as biomarker for hepatocellular carcinoma Keun Hur (Kyungpook National Univ., Biochemistry and Cell Biology, Korea) |
Date / Time | Nov. 18 (Thu), 12:25-13:55 | |
---|---|---|
Channel | Channel 2 | |
Chair(s) |
Hwoon-Yong Jung (Univ. of Ulsan, Korea) Chan Gyoo Kim (National Cancer Center, Korea) |
|
Speakers | 12:25-12:47 | The role of endoscopic management in afferent loop syndrome Mouen A. Khashab (Johns Hopkins Hosp., USA) |
12:47-13:09 | Novel approach for prevention of post-ESD bleeding Jun Chul Park (Yonsei Univ., Korea) | |
13:09-13:31 | Optimal use of the over-the-scope clip for treatment of GI complication Hang Lak Lee (Hanyang Univ., Korea) | |
13:31-13:53 | New modalities for treatment of post-operative anastomotic leak Hyuk Lee (Sungkyunkwan Univ., Korea) |
Date / Time | Nov. 18 (Thu), 12:25-13:55 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Hoon Jai Chun (Korea Univ., Korea) Dae Young Cheung (The Catholic Univ. of Korea, Korea) |
|
Speakers | 12:25-12:47 | Primary 3D culture-based research in upper GI cancer Su Youn Nam (Kyungpook National Univ., Korea) |
12:47-13:09 | Current status & future direction of AI in upper GI cancer Jie-Hyun Kim (Yonsei Univ., Korea) | |
13:09-13:31 | Current status & future direction of immunotherapy in upper GI cancer Minkyu Jung (Yonsei Univ., Medical Oncology, Korea) | |
13:31-13:53 | The Gastric Microbiome in Gastric Cancer David Y. Graham (Baylor College of Medicine, USA) |
Date / Time | Nov. 18 (Thu), 12:25-13:55 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Myung-Hwan Kim (Univ. of Ulsan, Korea) Michiaki Unno (Tohoku Univ. Graduate School of Medicine, Surgery, Japan) Yu-Wen Tien (National Taiwan Univ. Hosp., Taiwan) |
|
Discussant(s) | Joon Seong Park (Yonsei Univ., Surgery, Korea) Masayuki Sho (Nara Medical Univ., Japan) Chiung-Yu Chen (National Cheng Kung Univ. Hosp., Taiwan) |
|
Speakers | 12:25-12:45 | Upfront surgery for resectable/borderline-resectable pancreatic cancer Yoo-Seok Yoon (Seoul National Univ., Surgery, Korea) |
12:45-13:05 | Neoadjuvant therapy for resectable/borderline-resectable pancreatic ductal adenocarcinoma Sohei Satoi (Kansai Medical Univ., Surgery, Japan) | |
13:05-13:25 | Should we perform neoadjuvant therapy in resectable pancreatic cancer? Yan-Shen Shan (National Cheng Kung Univ. Hosp., Taiwan) | |
13:25-13:35 | Neoadjuvant chemotherapy for resectable/borderline-resectable pancreatic cancer Jae Min Lee (Korea Univ., Korea) | |
13:35-13:45 | The strategies for resectable / borderline-resectable pancreatic cancer Shigenori Ei (Tokai Univ. School of Medicine, Japan) | |
13:45-13:55 | Reshaping resectable/borderline-resectable pancreatic cancer in the era of precision medicine Chien-hui Wu (National Taiwan Univ. Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 12:25-13:55 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Do Young Kim (Yonsei Univ., Korea) Se Hyung Kim (Seoul National Univ., Radiology, Korea) |
|
Speakers | 12:25-12:47 | Radiomics-based clinical model for hepatocellular cancer Woo Kyoung Jeong (Sungkyunkwan Univ., Radiology, Korea) |
12:47-13:09 | Radiomics approaches in gastric cancer and colon cancer Sungwon Kim (Yonsei Univ., Radiology, Korea) | |
13:09-13:31 | Application of radiomics in inflammatory bowel disease Sung Kyoung Moon (Kyung Hee Univ., Radiology, Korea) | |
13:31-13:53 | The application of novel diagnostics and radiomics in the evaluation of pancreatic cystic lesions Somashekar G. Krishna (The Ohio State Univ. Wexner Medical Center, USA) |
Date / Time | Nov. 18 (Thu), 12:25-13:15 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Won-Choong Choi (Eulji Univ., Korea) Gab Jin Cheon (Univ. of Ulsan, Korea) |
|
Speakers | 12:25-12:35 | The Model for End-Stage Liver Disease-GFR Assessment in Liver Disease-Sodium (MELD-GRAIL-Na) Was an Inferior Predictor of Mortality Than the Model for End-Stage Liver Disease (MELD) in Korean Patients with Cirrhosis Jung Woo Kim (Konkuk Univ. Medical Center, Korea) |
12:35-12:45 | Comparison of Mortality Prediction between the Model for End-Stage Liver Disease-Lactate (MELD-La) and the Model for End-Stage Liver Disease (MELD) in Korean Patients with Liver Cirrhosis Jung Woo Kim (Konkuk Univ. Medical Center, Korea) | |
12:45-12:55 | Diagnostic Efficacy of Serum Asialo 1-Acid Glycoprotein Levels for Liver Fibrosis and Cirrhosis in CHB Compared to Healthy Subjects: A Prospective Study Yoon Seok Lee (Korea Univ. Guro Hosp., Korea) | |
12:55-13:05 | GMCSF Modulates Circulating Myeloid Derived Suppressor Cells and Tregs Suppressive Activity in Decompensated Cirrhotic Patients with Sepsis Rashi Sehgal (Institute of Liver and Biliary Sciences, India) | |
13:05-13:15 | Cardiac Diastolic Dysfunction Predicts Poor Prognosis in Patients with Decompensated Liver Cirrhosis Sahar Nasr (Univ. Hosp. Mohamed Taher Maamouri, Tunisia) |
Date / Time | Nov. 18 (Thu), 13:15-13:55 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Jeong Ill Suh (Dongguk Univ., Korea) Moon Seok Choi (Sungkyunkwan Univ., Korea) |
|
Speakers | 13:15-13:25 | Evaluating the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate in Virologically Suppressed Chronic Hepatitis B Patients Hyung Joon Yim (Korea Univ., Korea) |
13:25-13:35 | Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multi-Drugexperienced Chronic Hepatitis B Patients: A 60-Month Experience at Two Centers Junghun Kim (Konkuk Univ. Medical Center, Korea) | |
13:35-13:45 | Reduced Clinical Outcomes among Direct Anting Antiviral Treated Geriatric Patients with Chronic Hepatitis C: A Prospective, Multicenter Cohort Study Gwang Hyeon Choi (Seoul National Univ. Bundang Hosp., Korea) | |
13:45-13:55 | Pharmacovigilance Study of Ribavirin in Chronic Hepatitis C Patients in Different Clinical Settings of Hyderabad, Pakistan Mudassar Iqbal Arain (Univ. of Sindh, Jamshoro, Pakistan) |
Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 1 | |
Chair(s) |
Jin Mo Yang (The Catholic Univ. of Korea, Korea) Kwang Cheol Koh (Sungkyunkwan Univ., Korea) |
|
Speakers | 14:10-14:32 | The assessment of NAFLD using diagnostic algorithm Dae Won Jun (Hanyang Univ. Hosp., Korea) |
14:32-14:54 | The sequential application of systemic chemotherapy in advanced HCC Bo Hyun Kim (National Cancer Center, Korea) | |
14:54-15:16 | The treatment of nonselective beta blocker to patients with varices: (Who, When, and Which drug) Moon Young Kim (Yonsei Univ. Wonju, Korea) | |
15:16-15:38 | The selection of proper anti-viral agents to patients with CHB in each condition Jun Yong Park (Yonsei Univ., Korea) |
Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 2 | |
Chair(s) |
Soo-Heon Park (The Catholic Univ. of Korea, Korea) Yoshio Yamaoka (Oita Univ. Faculty of Medicine, Japan) |
|
Speakers | 14:10-14:32 | Physiologic and pathologic changes of GI tract of the elderly Ji Won Yoo (Univ. of Nevada, USA) |
14:32-14:54 | Atrophic gastritis and other chronic inflammation and gastric carcinogenesis Yoshio Yamaoka (Oita Univ. Faculty of Medicine, Japan) | |
14:54-15:16 | Antithrombotic-induced upper GI injury Chang Seok Bang (Hallym Univ., Korea) | |
15:16-15:38 | NSAIDs-induced upper GI injury Hee Man Kim (Yonsei Univ. Wonju, Korea) |
Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Yoon Tae Jeen (Korea Univ., Korea) Kwang Gi Kim (Gachon Univ., Biomedical Engineering, Korea) |
|
Speakers | 14:10-14:32 | Artificial intelligence-aided colonoscopy in polyp detection and differentiation Eun Hyo Jin (Seoul National Univ. Hosp. Healthcare System Gangnam Center, Korea) |
14:32-14:54 | AI assessment for the eligibility for endoscopic resection in patients with early CRC Wai Keung LEUNG (Li Ka Shing Faculty of Medicine, Univ. of Hong Kong, Hong Kong) | |
14:54-15:16 | AI applications in colorectal cancer prognosis and prediction Yoonjae Kim (Gachon Univ., Korea) | |
15:16-15:38 | Digital pathology in CRC diagnosis: Promise and hurdles Jeong Mo Bae (Seoul National Univ., Pathology, Korea) |
Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Young-Suk Lim (Univ. of Ulsan, Korea) Yasuhito Tanaka (Kumamoto Univ., Japan) Jia-Horng Kao (National Taiwan Univ. Hosp., Taiwan) |
|
Discussant(s) | Hyung Joon Yim (Korea Univ., Korea) Kiyoaki Ito (Aichi Medical Univ., Japan) Cheng-Yuan Peng (China Medical Univ. Hosp., Taiwan) |
|
Speakers | 14:10-14:30 | Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: A lesson from real-world evidence Jonggi Choi (Univ. of Ulsan, Korea) |
14:30-14:50 | Current status in hepatitis B management in Japan and future perspectives Tetsuya Hosaka (Toranomon Hosp., Japan) | |
14:50-15:10 | Towards Elimination of HBV Infection in Taiwan Chun-Jen Liu (National Taiwan Univ. Hosp., Taiwan) | |
15:10-15:20 | Identifying hepatocellular carcinoma risk of untreated chronic hepatitis B for timely antiviral intervention Gi-Ae Kim (Kyung Hee Univ., Korea) | |
15:20-15:30 | Role of host immune responses in achieving HBsAg loss Sachiyo Yoshio (The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Japan) | |
15:30-15:40 | Combined ALT/HBsAg kinetics for re-treatment decision in HBeAg-negative CHB patients with off-Nuc hepatitis flare Wen-Juei Jeng (Linkou Chang Gung Memorial Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Hyo Jong Kim (Kyung Hee Univ., Korea) Young Sook Park (Eulji Univ., Korea) |
|
Speakers | 14:10-14:30 | Application of treat-to-target strategy in clinical practice Eun Soo Kim (Kyungpook National Univ., Korea) |
14:30-14:50 | Choosing biologic agents beyond conventional therapy: When and What? Sung Noh Hong (Sungkyunkwan Univ., Korea) | |
14:50-15:10 | Optimal use of therapeutic drug monitoring Adam S. Cheifetz (Harvard Medical School, USA) | |
15:10-15:30 | Prevention of complications from IBD treatments Hyuk Yoon (Seoul National Univ., Korea) | |
15:30-15:40 | Discussion |
Date / Time | Nov. 18 (Thu), 14:10-14:50 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Yong Woo Choi (Konyang Univ., Korea) Seon Mee Park (Chungbuk National Univ., Korea) |
|
Speakers | 14:10-14:20 | The Predictor of Malignant in Intraductal Papaillary Neoplasm of the Bile Duct Sung Yong Han (Pusan National Univ. Hosp., Korea) |
14:20-14:30 | Pancreatic Adenocarcinoma Up-Regulated Factor Is a Novel Prognostic Biomarker and Therapeutic Target for Pancreatic Cancer: Standardization of Immunohistochemistry for Future Clinical Trials Kwangrok Jung (Seoul National Univ. Bundang Hosp., Korea) | |
14:30-14:40 | An Investigation of the Association between Inherited Lysosomal Storage Disorder Gene and PDAC Based on Two Hit Theory Hyung Rae Kim (Samsung Medical Center, Korea) | |
14:40-14:50 | Deep Single-Cell Transcriptomic Profile of Fibroblasts and Epithelial Cells in Pancreatic Ductal Adenocarcinoma Galam Leem (Severance Hosp., Korea) |
Date / Time | Nov. 18 (Thu), 14:50-15:40 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Ho Soon Choi (Hanyang Univ., Korea) Woo Jin Lee (National Cancer Center, Korea) |
|
Speakers | 14:50-15:00 | Prognostic Relevance of Sphingosine 1-Phosphate Receptor 2 and Takeda G Protein-Coupled Receptor 5 in Resected Extrahepatic Cholangiocarcinoma Yang Tae Park (Korea Univ. Guro Hosp., Korea) |
15:00-15:10 | A Terpene Preparation for the Pharmacological Prevention of Recurrence of Common Bile Duct Stone after Endoscopic Removal: A Prospective, Multicenter, Randomized Pilot Study Won Jae Yoon (Ewha Womans Univ. Seoul Hosp., Korea) | |
15:10-15:20 | Correlations of Bile and Duodenal Microbiota with Recurrent Common Bile Duct Stone Patients Jungnam Lee (Inha Univ. Hosp., Korea) | |
15:20-15:30 | Comparison of the Long-Term Outcomes of Proximal IgG4-Related Sclerosing Cholangitis and Distal IgG4-Related Sclerosing Cholangitis: A Retrospective Multicenter Study Sung Hyun Cho (Asan Medical Center, Korea) | |
15:30-15:40 | Clinical Benefit of Gemcitabine-Based Chemotherapy for Extreme Elderly Patients with Pancreatic Cancer Dong Wook Lee (Kyungpook National Univ., Korea) |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 1 | |
Chair(s) |
Han Chu Lee (Univ. of Ulsan, Korea) Oh Sang Kwon (Gachon Univ., Korea) |
|
Speakers | 15:55-16:17 | The present and future of therapeutic vaccine for viral hepatitis B Kyun-Hwan Kim (Sungkyunkwan Univ., Precision Medicine, Korea) |
16:17-16:39 | The present and future of therapeutic or preventative vaccine for viral hepatitis C Eui-Cheol Shin (Korea Advanced Institute of Science and Technology, Korea) | |
16:39-17:01 | COVID-19 vaccination in patients with chronic liver disease Jung Yeon Heo (Ajou Univ., Infectious Diseases, Korea) | |
17:01-17:23 | Vaccination strategy for patients with chronic liver disease and liver transplantation Eunjung Lee (Soonchunhyang Univ., Infectious Diseases, Korea) |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 2 | |
Chair(s) |
Sung Pyo Hong (CHA Univ., Korea) Seun Ja Park (Kosin Univ., Korea) |
|
Speakers | 15:55-16:17 | Gender perspective in esophageal cancer Do Hoon Kim (Univ. of Ulsan, Korea) |
16:17-16:39 | Sex differences in colon cancer: Epidemiology, genetics and therapy Bun Kim (National Cancer Center, Korea) | |
16:39-17:01 | Sex differences in the risk factors for hepatocellular carcinoma in Korea Sang-Wook Yi (Catholic Kwandong Univ., Preventive Medicine and Public Health, Korea) | |
17:01-17:23 | Sex matters: Impact on pathogenesis, presentation and treatment of inflammatory bowel disease Theresa T. Pizarro (Case Western Reserve Univ., USA) |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Kwang Ro Joo (Kyung Hee Univ., Korea) Seungmin Bang (Yonsei Univ., Korea) |
|
Speakers | 15:55-16:17 | Treatment approaches in borderline resectable and locally advanced pancreatic cancer Dong Wook Lee (Kyungpook National Univ., Korea) |
16:17-16:39 | Are we really making progress in the surgery of pancreatic cancer? Masayuki Sho (Nara Medical Univ., Japan) | |
16:39-17:01 | New agent and combination therapy for patients with metastatic pancreatic cancer Dong-Won Ahn (Seoul National Univ. Boramae Medical Center, Korea) | |
17:01-17:23 | Novel Radiotherapy in Pancreatic Cancer Eui Kyu Chie (Seoul National Univ., Radiation Oncology, Korea) |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Jae J. Kim (Sungkyunkwan Univ., Korea) Soo-Jeong Cho (Seoul National Univ., Korea) |
|
Speakers | 15:55-16:17 | COVID-19 and Endoscopy: Impact and Countermeasures Kwang Hyun Chung (Eulji Univ., Korea) |
16:17-16:39 | COVID-19 and IBD Yoo Jin Lee (Keimyung Univ., Korea) | |
16:39-17:01 | COVID-19 and Cancer June Young Chun (National Cancer Center, Korea) |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Seung-Jae Myung (Univ. of Ulsan, Korea) Tae Il Kim (Yonsei Univ., Korea) |
|
Speakers | 15:55-16:15 | Using organoids to understand colorectal cancer genetic drivers and guide treatment choice Susan Woods (Univ. of Adelaide, Australia) |
16:15-16:35 | Intestinal organoids as a tool for IBD research Jun Hwan Yoo (CHA Univ., Korea) | |
16:35-16:55 | Applications of patient-derived organoids in the management of colorectal cancer Younjoo Kim (Korea Cancer Center Hosp., Korea) | |
16:55-17:15 | Organoid-based regenerative and precision medicine for IBD Ryuichi Okamoto (Tokyo Medical Dental Univ., Japan) | |
17:15-17:25 | Discussion |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 6 | |
Chair(s) |
Hyun-Soo Kim (Yonsei Univ. Wonju, Korea) Jung Il Lee (Yonsei Univ., Korea) |
|
Speakers | 15:55-16:17 | Chemoprevention of hepatocellular carcinoma: Aspirin and statin Won-Mook Choi (Univ. of Ulsan, Korea) |
16:17-16:39 | Trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors Minyoung Lee (Yonsei Univ., Korea) | |
16:39-17:01 | Risk of gastric cancer development: Proton pump inhibitors vs histamine 2 receptor Ga-Yeong Shin (The Catholic Univ. of Korea, Korea) | |
17:01-17:23 | Severe clinical outcomes of COVID-19 associated with proton pump inhibitors In Kyung Yoo (CHA Univ., Korea) |